Results 41 to 50 of about 734,704 (283)

Surgical lung biopsy for the diagnosis of interstitial lung disease in England: 1997-2008 [PDF]

, 2016
Introduction: International guidelines and new targeted therapies for idiopathic pulmonary fibrosis have increased the need for accurate diagnosis of interstitial lung disease, which may lead to more surgical lung biopsies.
Fogarty, Andrew W., Hubbard, Richard B., Hutchinson, John P., McKeever, Tricia M., Navaratnam, Vidya   +4 more
core   +2 more sources

Progressive fibrosing interstitial lung disease: a clinical cohort (the PROGRESS study)

European Respiratory Journal, 2020
In patients with chronic fibrosing interstitial lung disease (ILD), a progressive fibrosing phenotype (PF-ILD) may develop, but information on the frequency and characteristics of this population outside clinical trials is lacking.
M. Nasser, S. Larrieu, S. Si-Mohamed, K. Ahmad, L. Boussel, M. Brevet, L. Chalabreysse, C. Fabre, S. Marque, D. Revel, F. Thivolet-Béjui, J. Traclet, S. Zeghmar, D. Maucort-Boulch, V. Cottin   +14 more
semanticscholar   +1 more source

Lung transplantation for interstitial lung disease

European Respiratory Review, 2021
Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis
S. Kapnadak, G. Raghu
semanticscholar   +1 more source

Predictors of progression in systemic sclerosis patients with interstitial lung disease

European Respiratory Journal, 2020
Systemic sclerosis (SSc) is a systemic autoimmune disease affecting multiple organ systems, including the lungs. Interstitial lung disease (ILD) is the leading cause of death in SSc.
O. Distler, S. Assassi, V. Cottin, M. Cutolo, S. Danoff, C. Denton, J. Distler, A. Hoffmann-Vold, S. Johnson, U. Müller Ladner, V. Smith, E. Volkmann, T. Maher   +12 more
semanticscholar   +1 more source

Genetic and environmental factors in interstitial lung diseases: current and future perspectives on early diagnosis of high-risk cohorts

Frontiers in Medicine, 2023
Within the wide scope of interstitial lung diseases (ILDs), familial pulmonary fibrosis (FPF) is being increasingly recognized as a specific entity, with earlier onset, faster progression, and suboptimal responses to immunosuppression.
Stefan Cristian Stanel, Stefan Cristian Stanel, Jack Callum, Pilar Rivera-Ortega   +3 more
doaj   +1 more source

Interstitial lung disease in children - genetic background and associated phenotypes [PDF]

, 2005
Interstitial lung disease in children represents a group of rare chronic respiratory disorders. There is growing evidence that mutations in the surfactant protein C gene play a role in the pathogenesis of certain forms of pediatric interstitial lung ...
A Clement, A Hamvas, A Hamvas, A Hamvas, A Hamvas, A Hamvas, AE Dunbar, ALA Katzenstein, AM Canakis, AQ Thomas, B Salaun, BC Hilman, BC Hilman, BO Abonyo, C Langston, C Lutz, CB Moens, CD Bingle, CG Cochrane, CG Li, CG Li, CR Mendelson, CR Mendelson, D Hatzis, D Warburton, DE deMello, DE deMello, DK Vorbroker, DS Konecki, DS Phelps, F Brasch, F Brasch, F Brasch, F Brasch, FS Cole, G Schmitz, G Yamano, GJ Breedveld, GT Cao, H Krude, HC Nielsen, HH Yang, HJ Wan, HJ Wan, HS Cameron, J de Blic, J Floros, J Johansson, J Johansson, J Massague, J McNeish, J Viitala, J Whitsett, JA Nightingale, JA Whitsett, JA Whitsett, JC Clark, JM Klein, JM Zhou, JP Bridges, JR Shaw-White, JR Shaw-White, K Akasaki, K Devriendt, K Ikeda, K Ikeda, K Tokieda, K Tokieda, KR Melton, L Nogee, L Sanchez-Pulido, L Zhou, LA Augusto, LA Augusto, LL Fan, LL Fan, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Nogee, LM Sutherland, M Bahuau, M Bahuau, M Bodzioch, M Griese, M Gustafsson, M Hallman, M Huizing, M Lahti, M Tredano, M Tredano, M Tredano, M Tredano, M Tredano, MD Bruno, MF Beers, MF Beers, MF Beers, MF Beers, MJ Metzelaar, MT Stahlman, MT Stahlman, MV Volpe, N Iwatani, NA Avila, NJ McKenna, P Kala, P Minoo, P Pantelidis, P Pantelidis, PA Stevens, PC Stillwell, PJ Miettinen, PL Ballard, PR Reynolds, PY Perera, R Haataja, R Haataja, R Marttila, RG Warr, RH Costa, RJ Bohinski, RJ Bohinski, RM du Bois, RM du Bois, RR Deterding, RS Amin, RT Allen, S Hawgood, S Hawgood, S Kimura, S Percopo, S Shulenin, S Shulenin, SA Rooney, SH Guttentag, SJ Copley, SW Glasser, SW Glasser, SW Glasser, SW Glasser, T Ueno, TE King, TE Weaver, TE Weaver, TE Weaver, V Makri, VH Kumar, WA Gahl, WE Lawson, WJ Wang, X Zeng, Y Nakatani, Z Lin   +162 more
core   +2 more sources

Research highlights from the 2018 ERS International Congress: interstitial lung diseases [PDF]

, 2019
This article reviews a selection of the scientific presentations on interstitial lung disease (ILD)/diffuse parenchymal lung disease (DPLD) that were made at the 2018 European Respiratory Society (ERS) International Congress in Paris.
Alfaro, Tiago M, Alfieri, Veronica, Antoniou, Katerina, Bargagli, Elena, Bonella, Francesco, Jeny, Florence, Kreuter, Michael, Molina-Molina, Maria, Moor, Catharina C, Nunes, Hilario, Poletti, Venerino, Renzoni, Elisabetta A, Spagnolo, Paolo, Wijsenbeek, Marlies S   +13 more
core   +4 more sources

Immune mechanisms in fibrotic pulmonary sarcoidosis

European Respiratory Review, 2022
Sarcoidosis is an immune-mediated disorder. Its immunopathology has been steadily mapped out over the past few decades. Despite this, the underpinning mechanisms for progressive fibrotic sarcoidosis is an almost uncharted area.
Praveen Weeratunga, David R. Moller, Ling-Pei Ho   +2 more
doaj   +1 more source

Imaging Lung Disease in Systemic Sclerosis [PDF]

, 2010
Interstitial lung disease and pulmonary hypertension (PH) are the most common cardiopulmonary findings in patients with systemic sclerosis (SSc). About two thirds of patients suffering from SSc develop scleroderma interstitial lung disease. PH is present
A Fischer, A Kahan, A Ramirez, A Vonk Noordegraaf, AC Arroliga, AU Wells, AU Wells, B Griffiths, B White, BC Gilliland, C Strange, D Bouros, D Launay, D Mukerjee, DA Lynch, Diane Strollo, DP Tashkin, DS Kim, E Diot, EA Kazerooni, EA Kim, EM Davas, FA Bianchi, GW Hunninghake, H Schurawitzki, HJ Kim, I Marie, I Pakas, J Fujita, J Goldin, JG Goldin, Jonathan Goldin, M Bhalla, M Lahcene, M Remy-Jardin, NL Muller, NS Goh, OA Minai, PI Latsi, PJ Clements, R Giacomelli, RG Ungerer, RM Shah, RM Silver, RW Tobin, SJ Swensen, SR Desai, T Kreig, TV Colby, V McLaughlin, VD Steen, WN Piper   +51 more
core   +3 more sources

Prognostic factors in chronic hypersensitivity pneumonitis

European Respiratory Review, 2020
Hypersensitivity pneumonitis (HP) is an immunologically mediated lung disease resulting from exposure to inhaled environmental antigens. Prognosis is variable, with a subset of patients developing progressive fibrosis leading to respiratory failure and ...
Andrew W. Creamer, Shaney L. Barratt
doaj   +1 more source